Switch to: References

Add citations

You must login to add citations.
  1. Administration of pro re nata medications by the nurse to incapacitated patients: An ethical perspective.Mojtaba Vaismoradi, Cathrine Fredriksen Moe, M. Flores Vizcaya-Moreno & Piret Paal - 2022 - Clinical Ethics 17 (1):5-13.
    The administration of pro re nata medications is the responsibility of the nurse. However, ethical uncertainties often happen due to the inability of incapacitated patients to collaborate with the nurse in the process of decision making for pro re nata medication administration. There is a lack of integrative knowledge and insufficient understanding regarding ethical considerations surrounding the administration of pro re nata medications to incapacitated patients. Therefore, they have been discussed in this paper and practical strategies to avoid unethical practices (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Surrogate decision making for unrepresented patients: Proposing a harm reduction interpretation of the best interest standard.Nada Gligorov & Phoebe Friesen - 2020 - Clinical Ethics 15 (2):57-64.
    Unrepresented patients are individuals who lack decision makingcapacity and have no family or friends to make medical decisions for them. This population is growing in number in the United States, particularly within emergency and intensive care settings. While some bioethical discussion has taken place in response to the question of who ought to make decisions for these patients, the issue of how surrogate medical decisions ought to be made for this population remains unexplored. In this paper, we argue that standard (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • The Role of a Hospital Ethics Consultation Service in Decision-Making for Unrepresented Patients.Andrew M. Courtwright, Joshua Abrams & Ellen M. Robinson - 2017 - Journal of Bioethical Inquiry 14 (2):241-250.
    Despite increased calls for hospital ethics committees to serve as default decision-makers about life-sustaining treatment for unrepresented patients who lack decision-making capacity or a surrogate decision-maker and whose wishes regarding medical care are not known, little is known about how committees currently function in these cases. This was a retrospective cohort study of all ethics committee consultations involving decision-making about LST for unrepresented patients at a large academic hospital from 2007 to 2013. There were 310 ethics committee consultations, twenty-five of (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • Making Medical Decisions for Incapacitated Patients Without Proxies: Part II.Eric Blackstone, Barbara J. Daly & Cynthia Griggins - 2020 - HEC Forum 32 (1):47-62.
    In the United States, there is no consensus about who should make decisions in acute but non-emergent situations for incapacitated patients who lack surrogates. For more than a decade, our academic medical center has utilized community volunteers from the hospital ethics committee to engage in shared decision-making with the medical providers for these patients. In order to add a different point of view and minimize conflict of interest, the volunteers are non-clinicians who are not employed by the hospital. Using case (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Making Medical Decisions for Incapacitated Patients Without Proxies: Part I.Cynthia Griggins, Eric Blackstone, Lauren McAliley & Barbara Daly - 2020 - HEC Forum 32 (1):33-45.
    To date no one has identified or described the population of incapacitated patients being treated in an inpatient setting who lack proxy decision-makers. Nor, despite repeated calls for protocols to be developed for decision-making, has any institution reported on the utilization of such a protocol. In 2005, our urban tertiary care hospital instituted a protocol utilizing community members of the ethics committee to meet with the medical providers and engage in shared decision-making for patients without proxies. We conducted a retrospective (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • Ethical Concerns and Procedural Pathways for Patients Who are Incapacitated and Alone: Implications from a Qualitative Study for Advancing Ethical Practice.Pamela B. Teaster, Erica Wood, Jennifer Kwak, Casey Catlin & Jennifer Moye - 2017 - HEC Forum 29 (2):171-189.
    Adults who are incapacitated and alone, having no surrogates, may be known as “unbefriended.” Decision-making for these particularly vulnerable patients is a common and vexing concern for healthcare providers and hospital ethics committees. When all other avenues for resolving the need for surrogate decision-making fail, patients who are incapacitated and alone may be referred for “public guardianship” or guardianship of last resort. While an appropriate mechanism in theory, these programs are often under-staffed and under-funded, laying the consequences of inadequacies on (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • The Ethical Standard for End-of-Life Decisions for Unrepresented Patients.Matthew Shea - forthcoming - American Journal of Bioethics.
    There has been increasing awareness of the medical and moral challenges in the care of unrepresented patients: those who cannot make their own medical decisions, do not have any surrogate decision maker, and have not indicated their treatment preferences. Most discussions have focused on procedural questions such as who should make decisions for these patients. An issue that has not gotten enough attention is the ethical standard that should govern medical decision making. I explore the question of which ethical standard (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Refusal of Representation in Advance Care Planning: A Case‐Inspired Ethical Analysis.Andrew T. Peters & Joshua M. Hauser - 2023 - Hastings Center Report 53 (2):3-8.
    Unrepresented patients—people without capacity to make medical decisions who also lack a surrogate decision‐maker—form a large and vulnerable population within the United States health care system. The burden of unrepresentedness has rightly prompted widespread calls for more and better advance care planning, in which still‐healthy patients are encouraged to designate a surrogate decision‐maker and thus avoid the risk of becoming unrepresented. However, we observe that some patients, even with available social contacts and access to adequate advance care planning services, simply (...)
    Download  
     
    Export citation  
     
    Bookmark